|
2024
|
Invention
|
Pharmaceutical composition for prevention or treatment of nonalcoholic fatty liver disease. The p... |
|
|
Invention
|
Bicyclic heterocycle compounds as tead inhibitor. The present invention relates to bicyclic heter... |
|
|
Invention
|
Pharmaceutical composition containing nintedanib with improved dissolution rate. The present inve... |
|
2023
|
Invention
|
Azetidinyl benzoxazole compounds and their use as mer and axl inhibitors. Compounds of formula (I... |
|
|
Invention
|
Fused bicyclic compounds and their use as mer and axl inhibitors. Compounds of formula (I) and a ... |
|
|
Invention
|
Novel compounds as gcn2 inhibitors, pharmaceutical compositions and uses thereof. Provided herein... |
|
|
Invention
|
Bicycle compounds as tead inhibitor.
The present invention relates to bicyclic heterocycle compo... |
|
|
Invention
|
Bicycle compounds as tead inhibitor. The present invention relates to bicyclic heterocycle compou... |
|
2022
|
Invention
|
Percutaneous absorption preparation for treating dementia comprising memantine enanthate. The pre... |
|
|
Invention
|
Oral composite formulation comprising evogliptin and metformin and method for preparing same. The... |
|
|
Invention
|
Tenofovir alafenamide-containing immediate-release formulation with enhanced formulation stabilit... |
|
|
Invention
|
2 inhibitors, pharmaceutical compositions and uses thereof. Provided herein are novel compounds, ... |
|
2021
|
Invention
|
Novel salt of empagliflozin derivative, which is sglt-2 inhibitor, and hydrate of salt. The prese... |
|
|
Invention
|
Acylated oxyntomodulin peptide analog. A novel peptide analog of acylated oxyntomodulin and its u... |
|
|
Invention
|
Pharmaceutical composition comprising donepezil, cilostazol, and aripiprazole for prevention, all... |
|
|
Invention
|
Percutaneous absorption preparation comprising donepezil with improved stability.
A percutaneous... |
|
|
Invention
|
Percutaneous absorption preparation comprising donepezil with improved stability. The present inv... |
|
|
Invention
|
Pyridopyrimidinone derivatives and their use as aryl hydrocarbon receptor modulators.
The presen... |
|
|
Invention
|
Pyridopyrimidinone derivatives and their use as aryl hydrocarbon receptor modulators. The present... |
|
|
Invention
|
Long-acting glp-1 and glucagon receptor dual agonist.
A novel long-acting acylated oxyntomodulin... |
|
|
Invention
|
Long-acting glp-1 and glucagon receptor dual agonist. The present invention relates to a novel lo... |
|
|
Invention
|
Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators.
The present i... |
|
|
Invention
|
Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators. The present in... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of diabetes and metabolic diseases associa... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis.
The pres... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis. The prese... |
|
2020
|
Invention
|
Anti-ror1/anti-4-1bb bispecific antibodies and uses thereof. The present disclosure provides an a... |
|
|
Invention
|
Composition comprising the extract of herbal combination for preventing or treating diabetic peri... |
|
|
Invention
|
Novel oxazolidinone derivatives.
The present invention relates to novel derivatives of oxazolidi... |
|
|
Invention
|
Composition comprising the extract of herbs for preventing or treating neurodegenerative disorder... |
|
|
Invention
|
Novel empagliflozin derivative which is sglt-2 inhibitor. The present invention relates to a nove... |
|
2019
|
Invention
|
Solubilization composition comprising rivaroxaban. The present invention relates to a solubilizat... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containin... |
|
|
Invention
|
Percutaneous absorption preparation comprising stabilized donepezil. A percutaneous absorption pr... |
|
|
Invention
|
Transdermal absorption preparation containing stabilized donepezil. The present invention relates... |
|
|
Invention
|
Method for preparation of sglt-2 inhibitor, dapagliflozin precursor. The present invention relate... |
|
2018
|
Invention
|
Sustained-release preparation comprising bepotastine or pharmaceutically acceptable salt thereof.... |
|
|
Invention
|
Percutaneous absorption preparation for treating dementia comprising donepezil. A percutaneous ab... |
|
|
Invention
|
Transdermal absorption agent comprising donepezil for treatment of dementia. The present inventio... |
|
|
Invention
|
Acylated oxyntomodulin peptide analog. The present invention relates to a novel peptide analog of... |
|
|
Invention
|
Acylated oxyntomodulin peptide analog. in vivoin vivo half-life, which are superior to those of n... |
|
|
Invention
|
Anti-dr5 antibody and use thereof. The present invention relates to an antibody that specifically... |
|
2017
|
Invention
|
Pharmaceutical composition comprising indigo pulverata levis extract or fraction thereof as effec... |
|
2016
|
Invention
|
2-yl)carbamate and crystal form thereof. The present invention relates to a novel salt of (R)-(1-... |
|
2015
|
G/S
|
Pharmaceutical agents affecting sensory organs;
pharmaceutical preparations for treating diabete... |
|
|
Invention
|
Substituted piperidines having gpr119 agonistic activity. The present invention relates to a subs... |
|
2008
|
G/S
|
Pharmaceuticals and medicines for the sensory organs;
vitamin preparations; pharmaceuticals and ... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment and
prevention of sexual dysfunction; pharmaceut... |
|
2005
|
G/S
|
Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuti... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment and
prevention of sexual disfunction, pharmaceut... |
